Profile

Intelligencia AI™ leads the way in leveraging curated and harmonized data, biomedical expertise and artificial intelligence (AI) with its patented technology to address significant challenges in the pharmaceutical industry. These challenges include lengthy drug development timelines, excessive costs, and unsustainable return on investment (ROI). Its suite of AI-powered solutions delivers actionable insights crucial in mitigating risks and enhancing decision-making associated with drug development by providing an accurate, unbiased assessment of a drug’s probability of success. Founded in 2017, Intelligencia AI is headquartered in New York, NY, with offices in Athens, Greece, and employs 110 individuals globally.

Mission: Empower life sciences companies to accelerate clinical development and de-risk business decisions with AI-driven solutions.

Vision: Our vision is to be a catalyst for change. By pioneering the advancement of AI in drug development, we support bringing groundbreaking therapies to market that will transform lives.

Visit www.intelligencia.ai

Key Products

Clinical and Biological Data: Harmonized, comprehensive data expertly curated and structured based on proprietary ontologies.

Intelligencia Portfolio Optimizer: A patented SaaS-based solution delivering accurate AI-driven probability of technical and regulatory success (PTRS) assessments, phase transitions and explainability for interventional, FDA-track clinical trials.

Dynamic Benchmarks: A SaaS-based platform for assessing clinical development success rates, incorporating dual-phase and non-linear progression with extensive filtering across all sponsors to provide more accurate historical success data.

Bespoke Insights: Custom projects led by customer success and insights experts designed to address critical business questions through tailored data extraction and analysis.

Key Executives

Dimitrios Skaltsas, CEO and Co-Founder

As the CEO and co-founder of Intelligencia AI, Dimitrios Skaltsas leads the Inc. 5000 ranked technology organization’s business and investment growth strategy and oversees vital functional areas of the multidisciplinary, growing team.

Alexandra Ferraro, Associate Director of Marketing

Alexandra drives the marketing function at Intelligencia AI, where she works on strategy and campaign execution to elevate the organization’s brand and drive demand for its AI-driven solution to help de-risk drug development.

Antonis Stampoulis, Director of Engineering

Antonis leads the engineering team that builds clinical trial data tooling, including tools for expert curation and automated data-capturing workflows.

Edoardo Madussi, Head of Business Development

Edo supports clinical development, portfolio management, and business development and licensing teams in the biopharma sector. He focuses on how implementing Intelligencia AI’s artificial intelligence platform enhances decision-making processes in drug development.

Gerry Liaropoulos, Director of Data Science

Gerry leads a multidisciplinary team that develops proprietary machine-learning algorithms and the development of new features that improve the accuracy and usability of the predictions.

Heracles Kasimis, Director of Engineering

Heracles oversees developing and maintaining the company’s external-facing and supportive software architecture, such as cloud infrastructure and data extraction pipelines.

Maria Georgananki, Director of Product

Maria drives product development strategies that align with the company’s vision while leveraging her background as a molecular cancer biologist to unite strong clinical knowledge with customer-centric product development.

Nikos Papadopoulos, Director of Finance

Nikos oversees the business’s financial operations, which include accounting, tax, payroll and budgeting.

Panos Karelis, Director of Insights Excellence

Panos leads the Center of Insights Excellence division, focusing on unlocking value for the company’s partners through best-in-class thought partnerships and bespoke analytics.

Phoebe Prosalika, Director of People Operations

Phoebe oversees all aspects of talent management, nurturing the organization’s culture and fostering employee engagement.

Customer Insights

“Thank you for informing and enabling our portfolio strategy with a continuous stream of insights across emerging trends and salient competitive threats in our space.” – VP of Portfolio Strategy, Biotech

“Intelligencia AI has provided great search and data automation capabilities on very specific scientific topics. The results are truly enhancing our strategy.” – Associate Director of External Innovation, Pharmaceutical Company

“Intelligencia AI’s platform [Portfolio Optimizer] to assess the probability of success of our portfolio programs is very powerful; it helps us make critical decisions in portfolio management.” – Head of Global Portfolio Management, Pharmaceutical Company

“We don’t see our partnership as a customer-based one, but we consider Intelligencia AI as an extended part of our team. – Head of Oncology, Biostats, Pharmaceutical Company

“The winning factors of Intelligencia AI are data quality and depth, PTRS drivers and regular communications.” – Head of Global Portfolio Management, Biopharma Company

Investors

• MTIP


• ZS


• Big Pi Ventures.

Competitors

• Evaluate Pharma


• IQVIA


• Insilico


• Global Data


• Norstella/Citeline.

Corporate Responsibility

They Raise the Bar: Excellence is not their destination but a continuous journey.

They Build Together: Teaming up with their colleagues, partners, customers and stakeholders takes them places they can’t go alone.

They are Humble: They approach their work and interactions with modesty, respect, and an open mindset.

They Care: They bring a deep sense of compassion and concern for the well-being of those they work with and recognize their people as their greatest asset.